A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)
Article in Pediatric Blood & Cancer (March 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Pediatric Blood & Cancer (March 2024)
Article in Advanced Healthcare Materials (May 2023)
Article in European Heart Journal - Case Reports (April 2023)